Jeff Yass’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$329 Sell
10,892
-7,271
-40% -$342 ﹤0.01% 13267
2026
Q1
$910 Buy
18,163
+1,109
+7% +$71 ﹤0.01% 13033
2025
Q4
$1.07K Sell
17,054
-286
-2% -$14 ﹤0.01% 12148
2025
Q3
$642 Buy
+17,340
New +$1.19K ﹤0.01% 12214
2025
Q2
Sell
-15,140
Closed -$348 13690
2025
Q1
$348 Buy
+15,140
New +$418 ﹤0.01% 12350

Other funds holding SXTPW

Jeff Yass's SXTPW Position: Q2 2026 in Review

Jeff Yass reduced its 60 Degrees Pharmaceuticals Warrant (SXTPW) stake by 40% in Q2 2026, selling an estimated $342 and leaving 10,892 shares worth $329. The position accounts for ﹤0.01% of the portfolio, ranked #13267.

Jeff Yass first reported a position in SXTPW in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.07K in Q4 2025. 5 funds tracked by Wall St. Rank hold SXTPW as of Q2 2026.

  • Jeff Yass held 10,892 shares of 60 Degrees Pharmaceuticals Warrant worth $329 as of Q2 2026.
  • Jeff Yass sold 7,271 60 Degrees Pharmaceuticals Warrant shares in Q2 2026, an estimated $342.
  • 60 Degrees Pharmaceuticals Warrant made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13267 holding.
  • Jeff Yass first reported a position in 60 Degrees Pharmaceuticals Warrant in Q1 2025 and has held it in 5 quarters since.
  • Jeff Yass's 60 Degrees Pharmaceuticals Warrant position peaked at $1.07K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.